While the broader market has struggled with the S&P 500 down 1.7% since September 2024, Waters Corporation has surged ahead as its stock price has climbed by 13.1% to $382.94 per share. This run-up might have investors contemplating their next move.
What a brutal six months it’s been for Hyster-Yale Materials Handling. The stock has dropped 27.8% and now trades at $45.09, rattling many shareholders. This may have investors wondering how to approach the situation.
While the broader market has struggled with the S&P 500 down 1.7% since September 2024, Custom Truck One Source has surged ahead as its stock price has climbed by 32.8% to $5.10 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Atkore has gotten torched over the last six months - since September 2024, its stock price has dropped 26% to $66 per share. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Exponent’s stock price has taken a beating over the past six months, shedding 26.7% of its value and falling to $81.90 per share. This may have investors wondering how to approach the situation.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at heavy transportation equipment stocks, starting with Oshkosh (NYSE:OSK).
AAR currently trades at $67.76 per share and has shown little upside over the past six months, posting a small loss of 2.6%.
Shareholders of PlayStudios would probably like to forget the past six months even happened. The stock dropped 20.7% and now trades at $1.19. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
What a brutal six months it’s been for USANA. The stock has dropped 31.7% and now trades at a new 52-week low of $27.43, rattling many shareholders. This may have investors wondering how to approach the situation.
Even during a down period for the markets, Clover Health has gone against the grain, climbing to $3.82. Its shares have yielded a 26.1% return over the last six months, beating the S&P 500 by 27.7%. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
